Previous close | 846.40 |
Open | 846.00 |
Bid | 841.40 x 0 |
Ask | 842.20 x 0 |
Day's range | 829.20 - 846.00 |
52-week range | 728.80 - 1,194.00 |
Volume | |
Avg. volume | 241,518 |
Market cap | 178.72B |
Beta (5Y monthly) | 0.20 |
PE ratio (TTM) | 37.82 |
EPS (TTM) | 22.26 |
Earnings date | N/A |
Forward dividend & yield | 19.00 (2.24%) |
Ex-dividend date | 09 May 2022 |
1y target est | 1,012.57 |
Coloplast will host a Meet the Management event on Wednesday, 31 August 2022. Kindly register before 5 August 2022 for in-person attendance. The event will take place between 11.00 - 18.00 CEST (Central European Summer Time), at Coloplast’s Headquarters in Denmark (Holtedam 3, 3050 Humlebaek, Denmark). Coloplast is delighted to invite institutional investors, equity analysts, and media to attend our Meet the Management event 2022. The event will be held in-person at our headquarters in Humlebaek
Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded an AscenDrive agreement with Premier, Inc. AscenDrive is a national program designed to standardize the care delivery process and help drive the highest-level commitment and savings for members. Effective July 1, 2022, Coloplast is one of two suppliers awarded the AscenDrive contract for ostomy products. Premier is a leading healthcare improvement company uniting an alliance of approximately 4,40
Yahoo Finance Live anchors discuss Sycamore and Franchise Group becoming the latest to submit bids for Kohl’s.